These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy. Rinaldi C; Tucci T; Maione S; Giunta A; De Michele G; Filla A J Neurol; 2009 Sep; 256(9):1434-7. PubMed ID: 19363628 [TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone. Cook A; Boesch S; Heck S; Brunt E; Klockgether T; Schöls L; Schulz A; Giunti P Acta Neurol Scand; 2019 Jun; 139(6):533-539. PubMed ID: 30887496 [TBL] [Abstract][Full Text] [Related]
17. Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia. Drinkard BE; Keyser RE; Paul SM; Arena R; Plehn JF; Yanovski JA; Di Prospero NA Arch Phys Med Rehabil; 2010 Jul; 91(7):1044-50. PubMed ID: 20599042 [TBL] [Abstract][Full Text] [Related]
18. Co-enzyme Q10 and idebenone use in Friedreich's ataxia. Parkinson MH; Schulz JB; Giunti P J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348 [TBL] [Abstract][Full Text] [Related]
19. Introduction. Idebenone in the treatment of Friedreich ataxia. Pandolfo M J Neurol; 2009 Mar; 256 Suppl 1():1-2. PubMed ID: 19283343 [No Abstract] [Full Text] [Related]